We investigated the usefulness of a one-tube, three-colour flow cytometric method for enumerating CD4 + and CD8 + lymphocytes. This method does not use any control antibodies and we compared it to the standard methods using either control and CDI4/CD45 antibodies or control antibodies only on 38 blood samples from healthy and human immunodeficiency virus-infected patients. The one-tube method showed good agreement with the other, more complicated methods and is therefore suitable for reliable enumeration of CD4 + and CD8 +
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Additional key phrases: T-lymphocytes, CD3+ antigen, CDI4+ antigen, CD45 + antigen Flow cytometry is a useful tool for identifying lymphocyte subsets on the basis of their expression of specific antigens. The CD3 + 4 + lymphocyte subset count is advised for monitoring disease activity and therapeutic effect in patients with human immunodeficiency virus (HIV) infection. The Centers for Disease Control and Prevention (CDC)l have proposed a specific protocol describing a comprehensive method, including several controls, in order to provide reliable CD4 + lymphocyte counts. Loken et aU have recommended a simpler method using CD14 and CD45 antibodies in a two-colour technique for optimal pre-selection of the lymphocyte population and to enable correction for contamination by non-lymphocyte cells in this population. The use of control reagents in the panel of antisera is common practice in clinical flow cytometry for quantifying the fluorescence intensity which distinguishes positive and negative cells and thus for correction of non-specific binding.
We investigated whether a one-tube, threecolour technique using a mixture of CD4, CDS and CD3 antisera could be used to enumerate CD3 +, CD3 + 4 + and CD3 + S+ lymphocytes directly. The advantage of this method would be that the control antibody measurements, as well Correspondence: Dr J HolTmann.
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as the pre-selection with CDI4/CD45 antisera, could be eliminated. We compared results obtained by this method with those obtained by the method of Loken et al. 2 
MATERIALS AND METHODS

Materials
All antisera were monoclonal immunoglobulin G 1 (IgG 1) and were commercially obtained: CD3 (clone SK 7) labelled with peridinin chlorophyll protein (PerCP) and control IgG I (clone X40) labelled with PerCP were from Becton Dickinson, San Jose CA, USA. CD4 (clone MT31O) labelled with fluorescein isothiocyanate (FITC), CDS (clone DK25) labelled with phycoerythrin (PE), control IgG1-FITC (clone CLB 203) and IgG1-PE (clone CLB203) were from DAKO, Glostrup, Denmark. CDI4-FITC (clone 8G3) and CD45-PE (clone l5D9) were from the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands. All antibodies were used in saturating dilutions.
Calibrite flow cytometer beads, polystyrene test tubes (Falcon, type 2052) and f1uorescenceactivated cell sorter (F ACS) lysing solution (diluted x 10 with distilled water before use) were purchased from Becton Dickinson. Diluid 1000 (isotonic fluid) was from J T Baker, Deventer, The Netherlands. Blood anticoagulated with tripotassium ethylene diamine tetraacetic acid (1'5 mg/ml. final concentration) was obtained from 28 healthy volunteers and 10 persons infected with HIV.
Immunofluorescent staining method
The staining was performed within 2 h of collection of the blood sample. To each of three test tubes, 50 J1L whole blood was added and then in the first tube (one-tube, three-colour method) 10J1L CD4-FITC/CD8-PE antiserum mixture and 10J1L CD3-PerCP antiserum were added. For comparison with established methods, 10J1L CDI4/CD45 antiserum mixture was added to the second tube and 10J1L control IgG,-FITC/lgG,-PE mixture and 10J1L control IgG1-PerCP was added to the third tube.
Subsequently, the tubes with blood and antisera were mixed briefly and incubated for 15 min at ambient temperature in the dark. Following incubation, 2 mL lysing solution was added in order to lyse the erythrocytes. The suspension was quickly mixed and incubated for 10 min at ambient temperature in the dark. After centrifugation at 500 g for 5 min the supernatant was removed by aspiration and discarded. The cell pellet was subsequently washed with 2 mL isotonic fluid. The remaining cells were resuspended in 0·3 mL isotonic fluid. This cell suspension was analysed within I h after completing the staining in a FACScan flow cytometer using the FACScan research software v2.6. (Becton Dickinson). Optimal instrument settings were used, based on calibration using Calibrite microbeads; the settings were checked daily. Acquisition of 10000 events was performed. The fluorescence analysis was confined to the lymphocytes by gating on their forward and sideward light scatter properties.
The results were presented as two-dimensional dot plots of FL I (FITC) vs FL2 (PE), FL I vs FL3 (PerCP) and FL2 vs FU. For the one-tube, three-colour method quadrants were set based on visual examination of the pattern of fluorescence in FL I vs FL3 and FL2 vs FU dot plots.
Next, the total fractions of CD3 +, CD3 + 4 + and CD3 + 8 + lymphocytes were calculated.
The concentrations of positive lymphocytes in whole blood (in 10 9/L) were calculated using lymphocyte counts obtained with a Bayer/ Technicon H I or H2 cell counter (Bayer Diagnostics, Tarrytown, NY, USA).
Method using CD14/CD45 plus control antibodies For comparison, a method using CDI4/CD45 plus control antibodies was used. The CDI4/ CD45 antisera combination was used according to the method of Loken et aU In summary, the fluorescence pattern obtained using CDI4/CD45 was used to select the population of lymphocytes (CD45 + bright, CDI4 negative); a representative example is shown in Fig. I(a) . Thereafter, the lymphocytes included in this fluorescence gate were localized in the forward vs sideward light scatter dot plot and a light scatter gate was set around these lymphocytes. Next, the fluorescence gate was turned ofT, leaving only the light scatter gate active. Subsequently, dot plots of control antibodies were used to define quadrant settings, separating unstained and stained cells in such a way that the negative region contained at least 99% of the unstained lymphocytes for any fluorescence parameter. Method using control antibodies Another established method was used for comparison, using control antibodies but no CDI4/CD45 antibodies. Briefly, selection of lymphocytes was performed using light scatter gating. Next, the control antibodies were used to define quadrant settings, based on criteria described above. In the corresponding sample, the same quadrant settings were used in dot plots of CD4 vs CD3 and CD8 vs CD3 for enumerating CD3 +, CD3 + 4 + and CD3 + 8 + lymphocytes.
RESULTS
Comparison of the one-tube, three-colour method with the method using CD14/CD45 plus control antibodies The results of the one-tube, three-colour fluorescence method were compared with the results of the method using CDI4/CD45 plus control antibodies. The relation between both methods, for each T-cel1 subset, is shown in Fig. 2 (a-e) using Bland-Altman difference plots. The mean difference in CD3 + lymphocytes between the one-tube, three-colour technique and the CDI4/ 45 plus control method was -0,11 x 10 9/L [95% confidence interval (CI): -0·08 to -0'14].
Corresponding data for CD3 + 4 + lymphocytes were -0'06 x 109/L (95% CI: -0'03 to -0'08) and for CD3 + 8 + lymphocytes were -0'05x 10 9/L (95% CI:-0'04 to -0'06). The mean differences were identical in the healthy individuals and the HIV-infected patients, as shown in Fig. 2(a-e) .
Comparison of the one-tube, three-eolour method with the method using control antibodies
The results of the one-tube, three-colour fluorescence method were compared with the results of the method using control antibodies. The relation between both methods, in healthy individuals. is shown in Fig, 3 (ac) using Bland Altman difference plots, The mean difference in CD3 + lymphocytes between the one-tube. three-colour technique and the method using control antibodies was 0-000 x 109(L (95% CI: -0-003 to 0-003)_ Corresponding differences for CD3 + 4 + lymphocytes were -0·002 x 10 9/L (95% CI: -0·005 to 0,001) and for CD3+8+ lymphocytes were -O'OlD x lD 9 /L (95% CI: -0,017 to -0'004).
DISCUSSION
Because potential contamination by non-lymphocytes in the lymphocyte light scatter gate was expected to be higher in HIV-infected subjects due to their low lymphocyte counts, we included a number of samples from these subjects in our evaluation.
On comparison of the results obtained using the one-tube, three-colour fluorescence method with those of the method using the CDI4/CD45 plus control antibodies according to Loken et aU, the 95% confidence intervals of the mean differences in lymphocyte subset count excluded zero, indicating a systematic bias. The results of our one-tube, three-colour method were always lower than those of the comparison method, excluding systematic overestimation of lymphocyte subset counts due to contaminating nonlymphocytes. These small differences, although statistically significant, were considered clinically insignificant, especially since the limits of agreement are rather narrow. This indicates that our method and the method using the CDI4/ CD45 plus control antibodies have similar and acceptable precision.
Comparing the results obtained using our method with the method using control antibodies, the 95% confidence intervals of the mean differences in lymphocyte subset count included zero, indicating no systematic bias. The limits of agreement are much narrower than those described above. The wider limits of agreement obtained in the comparison of our method and the method using CDI4/CD45 plus control antibodies indicates that the precision is adversely affected by using the CDI4/CD45 antibodies. These findings clearly show that a correct selection of the lymphocytes can be performed using their light scatter properties alone and, furthermore, that quadrant settings for discriminating between negative and positive fluorescence can be set without using control antibodies, at least for this specific application.
Alternatively, we have tried another approach for calculating T-lymphocyte subsets. Cells showing positive fluorescence of CD3-PerCP were selected by gating on FL3 fluorescence only. This population was assumed to contain only CD3 + T-cells, but appeared to be Ann Clin Biochem 1999: 36 contaminated with approximately 15% granulocytes. Granulocytes generally exhibit a certain level of autofluorescence and the FL3 gate therefore included granulocytes with the strongest autofluorescence. For that reason, reliable and accurate calculation of CD3 + 4 + and CD3 + 8 + lymphocytes was not possible in this way.
We have shown that in order to determine CD4 + and CD8 + counts within a CD3 + lymphocyte population, a one-tube, three-colour direct immunofluorescence protocol makes the use of control antibodies superfluous, and the same holds true for the CDI4/CD45 antisera combination. Omitting these antibodies enables a considerable saving of cost and labour. A similar one-tube, three-colour approach for enumerating CD4 + lymphocytes and determination of the CD4:CD8 ratio was evaluated by McCoy et at. 3 The mean CD4 + counts obtained with their method were 7·4% lower than those obtained with a two-colour panel as recommended by the CDC. I The mean difference in the CD3 + 4 + count of our method compared well with the results of McCoy et at} namely, 7·9% lower. The latter authors examined their data using regression analysis, whereas our results were examined using a statistical approach which is in agreement with modem practice."
In the three-colour technique described by Lillevang et af.5 neither CD l4/CD45 antisera combination nor control antibodies were used. They used a CD45-FITCjCD3-PE/CD4-PerCP antisera combination and lymphocytes were gated using CD45/sidewards scatter (SSC). Then the number of CD3 + and CD4 + lymphocytes was determined. Using such a gate setting, they claimed that no correction for purity was necessary since debris and monocytes are excluded. Using a second antisera mixture, CD8-FITCjCD4-PE/CD3-PerCP, these authors selected T-lymphocytes using CD3/SSC. The number of CD3 + 8 + lymphocytes was subsequently calculated. In our opinion, the disadvantages of their approach are the requirement for two different gate settings for performing the complete determination and the increased cost due to the use of extra CD3 and CD4 antisera.
CONCLUSION
The one-tube, three-colour immunofluorescence method presented here provides clinically valid results at considerably lower cost and can be recommended for routine use in clinicallaboratones equipped with a flow cytometer.
